Written Question·Department of Health and Social Care·UIN 96071

Abiraterone

Tabled: 1 December 2025

Answered: 2 February 2026

Question

Danny Beales

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 October 2025 to Question 83204, what step he is taking to secure a recurrent budget for abiraterone in high risk, non-metastatic prostate cancer, in the context of it b

Answer

Dr Zubir Ahmed

We are pleased to confirm that NHS England announced on 16 January that patients with non‑metastatic prostate cancer will now have access to abiraterone in combination with prednisolone, where it is deemed to be clinically beneficial. This development has...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 96071) →